Australia Explains Cost Recovery Under New IVD Regulations

International Medical Device Regulatory Monitor
KEYWORDS International
A A

In vitro diagnostics (IVDs) manufacturers and sponsors will now have to pay regulatory fees similar to those exacted from medical device companies under a new regulatory system that went into effect in Australia July 1.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $10.00